Promethos Capital, LLC Jazz Pharmaceuticals PLC Transaction History
Promethos Capital, LLC
- $264 Billion
- Q2 2024
A detailed history of Promethos Capital, LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Promethos Capital, LLC holds 70 shares of JAZZ stock, worth $7,800. This represents 0.0% of its overall portfolio holdings.
Number of Shares
70
Previous 70
-0.0%
Holding current value
$7,800
Previous $8.43 Million
11.37%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding JAZZ
# of Institutions
500Shares Held
57.4MCall Options Held
155KPut Options Held
152K-
Vanguard Group Inc Valley Forge, PA6.32MShares$705 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.15MShares$685 Million0.02% of portfolio
-
Lsv Asset Management Chicago, IL2.48MShares$276 Million0.58% of portfolio
-
Capital World Investors Los Angeles, CA2.02MShares$225 Million0.04% of portfolio
-
State Street Corp Boston, MA2.02MShares$225 Million0.01% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $6.98B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...